|BSE: 500087||Sector: Health care|
|NSE: CIPLA||ISIN Code: INE059A01026|
|BSE 00:00 | 24 Apr 2020||Cipla Ltd|
|NSE 05:30 | 01 Jan 1970||Cipla Ltd|
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApril 2, 2020, 8:26 am | Source: BSE
Press release - Successful completion of Phase-3 clinical study for generic version of GSKs Advair Diskus?